In the BioHarmony Drug Report Database

"Preview" Icon

Fosdenopterin

Nulibry (fosdenopterin) is a small molecule pharmaceutical. Fosdenopterin was first approved as Nulibry on 2021-02-26. Nulibry’s patent is valid until 2025-01-31 (FDA).

 

Trade Name

 

Nulibry
 

Common Name

 

fosdenopterin
 

ChEMBL ID

 

CHEMBL2338675
 

Indication

 

 

Drug Class

 

Phosphoro-derivatives

Image (chem structure or protein)

Fosdenopterin structure rendering